openPR Logo
Press release

Acid Sphingomyelinase Deficiency Market Size to Exhibit Moderate Growth by 2034, Evaluates DelveInsight

01-30-2025 11:55 AM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Acid Sphingomyelinase Deficiency Drugs Market

Acid Sphingomyelinase Deficiency Drugs Market

DelveInsight's "Acid sphingomyelinase deficiency Market Insight, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the acid sphingomyelinase deficiency historical and forecasted epidemiology as well as the acid sphingomyelinase deficiency market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Discover Key Insights into the Acid Sphingomyelinase Deficiency Market with DelveInsight's In-Depth Report @ Acid Sphingomyelinase Deficiency Market Size- https://www.delveinsight.com/sample-request/acid-sphingomyelinase-deficiency-asmd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Acid Sphingomyelinase Deficiency Market Report
• In December 2024:- Sanofi- A Prospective Observational Study to Assess the Long-term Safety and Immunogenicity of Olipudase Alfa Therapy During Routine Clinical Care in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency. Ancillary protocol-specified procedures to address the study objectives (eg, assessment of ADA) may be considered outside the standard of care for acid sphingomyelinase deficiency (ASMD), but the study methodology remains non-interventional, as the additional collection of data from participants will not dictate treatment.
• The global incidence is estimated to range from 0.4 to 0.6 cases per 100,000 newborns. These figures are likely underestimated, suggesting that the actual incidence may be higher.
• Acid sphingomyelinase deficiency impacts both males and females equally, showing no significant gender disparity in its prevalence.
• Patients with Niemann-Pick disease type A disease develop symptoms as early as age 3 months. Niemann-Pick disease type B has a variable age of presentation but frequently appears early in childhood, when hepatosplenomegaly is detected and symptoms of lung involvement may occur.
• The leading Acid Sphingomyelinase Deficiency Companies such as Sanofi Genzyme, Orphazyme, Takeda Pharmaceutical, Actelion Pharmaceuticals, and others.
• Promising Acid Sphingomyelinase Deficiency Therapies such as Olipudase alfa/GZ402665/ Recombinant human acid sphingomyelinase, and others.

Stay ahead in the Acid Sphingomyelinase Deficiency Therapeutics Market with DelveInsight's Strategic Report @ Acid Sphingomyelinase Deficiency Market Outlook- https://www.delveinsight.com/sample-request/acid-sphingomyelinase-deficiency-asmd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Acid Sphingomyelinase Deficiency Epidemiology Segmentation in the 7MM
• Total Diagnosed Cases of Acid Sphingomyelinase Deficiency
• Total Treated Cases of Acid Sphingomyelinase Deficiency

Download the report to understand which factors are driving Acid Sphingomyelinase Deficiency epidemiology trends @ Acid Sphingomyelinase Deficiency Prevalence- https://www.delveinsight.com/sample-request/acid-sphingomyelinase-deficiency-asmd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Acid Sphingomyelinase Deficiency Approved Drugs
XENPOZYME (olipudase alfa): Sanofi
XENPOZYME, a hydrolytic lysosomal sphingomyelin-specific enzyme replacement therapy, is designed to replace deficient or defective acid sphingomyelinase (ASM), an enzyme that allows for the breakdown of the lipid sphingomyelin. In individuals with acid sphingomyelinase deficiency, the deficiency in the ASM enzyme leads to sphingomyelin accumulation in various tissues. XENPOZYME is not expected to cross the blood-brain barrier or modulate CNS manifestations of acid sphingomyelinase deficiency. XENPOZYME has not been studied in patients with acid sphingomyelinase deficiency type A.

Acid Sphingomyelinase Deficiency Drugs Market Insights
Enzyme replacement therapy (ERT) for acid sphingomyelinase deficiency is a pivotal treatment that restores deficient sphingomyelinase enzyme activity, thereby mitigating the accumulation of sphingomyelin and alleviating disease symptoms. Administered via intravenous infusion, ERT has been shown to reduce hepatosplenomegaly, improve hematological parameters, and stabilize neurological functions. While effective, ERT requires ongoing administration and is associated with potential side effects such as infusion reactions and allergic responses. The current market includes FDA-approved therapies like olipudase alfa, and research continues to refine treatment protocols and explore combination strategies to enhance patient outcomes and manage long-term treatment challenges.

Get In-Depth Knowledge on Acid Sphingomyelinase Deficiency Market Trends and Forecasts with DelveInsight @ Acid Sphingomyelinase Deficiency Treatment Market- https://www.delveinsight.com/sample-request/acid-sphingomyelinase-deficiency-asmd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Acid Sphingomyelinase Deficiency Market Outlook
The Acid sphingomyelinase deficiency therapeutics market remains in its early stages, with significant unmet needs and ongoing research efforts. The rarity of the disease and the high costs associated with drug development pose challenges, but the development of novel therapies and increasing awareness offer promising opportunities for addressing this complex condition. Continued investment in research and development, along with strategic collaborations, will be key to advancing treatment options and improving patient outcomes.

Scope of the Acid Sphingomyelinase Deficiency Market Report
• Study Period: 2020-2034
• Coverage: 7MM
• Acid Sphingomyelinase Deficiency Companies: Sanofi Genzyme, Orphazyme, Takeda Pharmaceutical, Actelion Pharmaceuticals, and Many Others.
• Acid Sphingomyelinase Deficiency Therapies- Olipudase alfa/GZ402665/ Recombinant human acid sphingomyelinase, and others.
• Acid Sphingomyelinase Deficiency Therapeutic Assessment: Acid Sphingomyelinase Deficiency current marketed and Acid Sphingomyelinase Deficiency emerging therapies
• Acid Sphingomyelinase Deficiency Market Dynamics: Acid Sphingomyelinase Deficiency market drivers and Acid Sphingomyelinase Deficiency market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Acid Sphingomyelinase Deficiency Unmet Needs, KOL's views, Analyst's views, Acid Sphingomyelinase Deficiency Market Access and Reimbursement

Unlock Strategic Insights with DelveInsight's Comprehensive Acid Sphingomyelinase Deficiency Market Report @ Acid Sphingomyelinase Deficiency Market Drivers and Barriers- https://www.delveinsight.com/sample-request/acid-sphingomyelinase-deficiency-asmd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Report Introduction
3. Executive Summary of Acid Sphingomyelinase Deficiency (ASMD)
4. Key Events
5. ASMD Epidemiology and Market Forecast Methodology
6. ASMD Market Overview at a Glance
7. Disease Background and Overview: ASMD
8. Treatment and Management
9. Epidemiology and Patient Population of ASMD in the 7MM
10. Patient Journey
11. Marketed Therapies
12. ASMD: Seven Major Market Analysis
13. Unmet Needs
14. SWOT Analysis
15. KOL Views
16. Market Access and Reimbursement
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight

List of Top Selling Market Research Reports in 2025

varicose vein treatment devices market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
vascular access devices market- https://www.delveinsight.com/report-store/vascular-access-device-market
indwelling catheters market- https://www.delveinsight.com/report-store/indwelling-catheters-market
healthcare competitive benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
lymphoedema market- https://www.delveinsight.com/report-store/lymphoedema-market
pacemakers market- https://www.delveinsight.com/report-store/pacemakers-market
myeloproliferative neoplasms market- https://www.delveinsight.com/report-store/myeloproliferative-neoplasms-market
surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
NK cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
novel drug delivery devices market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
testicular neoplasm market- https://www.delveinsight.com/report-store/testicular-cancer-pipeline-insight
phototherapies for psoriasis market- https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
skin neoplasm market- https://www.delveinsight.com/report-store/nonmelanoma-skin-cancer-market
microscopy device market- https://www.delveinsight.com/report-store/microscopy-device-market
bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
urea cycle disorders market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-market
total knee arthroplasty market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
cardiac implantable electronic devices market- https://www.delveinsight.com/blog/implantable-cardiac-monitors-market
dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-epidemiology-forecast-insight
lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
medical marijuana market- https://www.delveinsight.com/blog/medical-marijuana-market
asperger syndrome market- https://www.delveinsight.com/report-store/autism-spectrum-disorder-asd-market
catheter stabilization devices market- https://www.delveinsight.com/sample-request/catheter-stabilization-securement-device-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acid Sphingomyelinase Deficiency Market Size to Exhibit Moderate Growth by 2034, Evaluates DelveInsight here

News-ID: 3842025 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Acid

Adipic Acid Market, Adipic Acid Market share, global Adipic Acid Market, Adipic …
The research is a great blend of qualitative and quantitative data, covering significant market developments, industry and competitive issues, gap analysis, and new opportunities and trends in the Adipic Acid Market. The report's goal is to give cutting-edge market knowledge and assist decision makers in making smart investment decisions by presenting an overview of the Global Flooring Adhesives Market. Additionally, the research identifies and analyses upcoming trends, as well as
Chloroacetic Acid (Monochloroacetic Acid) Market 2022 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Chloroacetic Acid (Monochloroacetic Acid) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Chloroacetic Acid (Monochloroacetic Acid) market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Chloroacetic Acid (Monochloroacetic Acid)
Bio-Based Platform Chemicals Market Value to Expand at $18.8 Billion by 2021 : I …
"North America and Europe, collectively accounted for more than half of the total platform chemicals market in 2015 and are expected to maintain this throughout the forecast period. Key factors responsible for the market growth in these regions include, stringent government regulations imposed on the consumption of toxic chemicals and rapid adoption of innovative technologies. However, Asia-Pacific is projected to be the fastest-growing segment due to increase in industrial activities
Dimeric fatty acid Market, Dimeric fatty acid Market Growth, Dimeric fatty acid …
The Fact.MR report covers all the recent developments in the dimeric fatty acid market. The report features a list of market leaders and new entrants in the dimeric fatty acid market, including Croda International Plc., Kraton Corporation, Oleon NV, Shandong Huijin Chemical Co. Ltd., Liancheng Baixin Science and Technology Co. Ltd., Jiangsu Jinma Oil Technology Development Co., Ltd., Jiangsu Yonglin Oleochemical Co. Ltd., Anqing Hongyu Chemical Co., Ltd., Aturex Group,
Feed Acid Market Report 2018: Segmentation by Type (Acetic Acid, Butyric Acid, F …
Global Feed Acid market research report provides company profile for Nutrex NV, Novozymes Adisseo France SAS, Pancosma SA, Perstorp Holding AB, BASF SE, Biomin GmbH, Kemin Industries Inc, Kemira Oyj, Novus International Inc and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and
Feed Acidifiers Market Report 2018: Segmentation by Type (Propionic Acid, Formic …
Global Feed Acidifiers market research report provides company profile for Yara International ASA (Norway), Kemin Industries Inc. (US), Kemira OYJ (Finland), Biomin Holding GmbH (Austria) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.